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Mus musculus deficient for secretory
antibodies show delayed growth with an
altered urinary metabolome
Kim R. Simpfendorfer1,7†, Nancy Wang1*† , Dedreia L. Tull2, David P. De Souza2, Amsha Nahid2, Andre Mu1,3,4,
Dianna M. Hocking1, John S. Pedersen5, Odilia L. C. Wijburg1†, Malcolm J. McConville2,6† and Richard A. Strugnell1*†
Abstract
Background: The polymeric immunoglobulin receptor (pIgR) maintains the integrity of epithelial barriers by
transporting polymeric antibodies and antigens through the epithelial mucosa into the lumen. In this study, we
examined the role of pIgR in maintaining gut barrier integrity, which is important for the normal development in
mice.
Methods: Cohorts of pIgR−/− mice and their wildtype controls were housed under Specific Pathogen Free (SPF)
conditions and monitored for weight gain as an indicator of development over time. The general physiology of the
gastrointestinal tract was analysed using immunohistochemistry in young (8–12 weeks of age) and aged mice (up
to 18 months of age), and the observed immunopathology in pIgR−/− mice was further characterised using flow
cytometry. Urinary metabolites were analysed using gas chromatography-mass spectrometry (GC-MS), which
revealed changes in metabolites that correlated with age-related increase in gut permeability in pIgR−/− mice.
Results: We observed that pIgR−/− mice exhibited delayed growth, and this phenomenon is associated with low-
grade gut inflammation that increased with ageing. The gross intraepithelial lymphocytic (IEL) infiltration
characteristic of pIgR−/− mice was redefined as CD8α+αβ+ T cells, the majority of which expressed high levels of
CD103 and CD69 consistent with tissue resident memory T cells (TRM). Comparison of the urinary metabolome
between pIgR−/− and wild-type mice revealed key changes in urinary biomarkers fucose, glycine and Vitamin B5,
suggestive of altered mucosal permeability. A significant increase in gut permeability was confirmed by analysing
the site-specific uptake of sugar probes in different parts of the intestine.
Conclusion: Our data show that loss of the secretory antibody system in mice results in enhanced accumulation of
inflammatory IELs in the gut, which likely reflects ongoing inflammation in reaction to gut microbiota or food
antigens, leading to delayed growth in pIgR−/− mice. We demonstrate that this leads to the presence of a unique
urinary metabolome profile, which may provide a biomarker for altered gut permeability.
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Background
The mucosal surface lining of the gastrointestinal tract
(GIT) is composed of microvilli and villi that increase
the surface area and allow for efficient nutrient absorp-
tion into the body. The folded epithelium represents the
largest surface area of the body exposed to the external
environment, and the challenge of maintaining function
and protection of this barrier is significant.
The mucosal immune system has evolved to protect the
epithelia against pathogens and reduce the pathologies
that might be expected if the highly inflammatory bacter-
ial pathogen-associated molecular patterns (PAMPs) make
contact with their cognate cellular ligands, including
Toll-like and nucleotide-binding oligomerisation domain
(NOD)-like receptors. In humans, approximately 3 g of
secretory IgA (SIgA) and SIgM is secreted into the muco-
sal lumen of the GIT each day (Conley and Delacroix
1987). In particular, SIgA has been considered as a major
defence against pathogens seeking to enter the epithelium
(Strugnell and Wijburg 2010). In addition, the secretory
immune system may also mediate the ‘excretion’ of anti-
gens from the sub-epithelial tissues (Kaetzel et al. 1991).
This excretion occurs through both specific and ‘polyspe-
cific’ SIgA which bind antigens on the basolateral side of
the epithelia surface after transepithelial or paracellular
movement of antigens and microbes through the epithelial
barrier. In this excretion hypothesis, it is argued that the
secretory antibody (SAb) performs a key function in de-
pleting antigen from the systemic compartment. Accord-
ing to Lamm’s model (Kaetzel et al. 1991), SIgA-antigen
complexes bind to the polymeric immunoglobulin recep-
tor (pIgR) at the basolateral surface of the epithelium, trig-
gering receptor-mediated endocytosis and subsequent
exocytosis of antibody-antigen complexes from the apical
surface into the GIT lumen.
In the absence of SAbs across the GIT, movement
of gut-derived antigens into systemic sites becomes
less controlled. We have previously shown that
antigen-specific T cells undergo more proliferation in
response to orally fed antigen in pIgR−/− mice than
wild-type B6 mice (Sait et al. 2007), suggesting that
immunological tolerance may be impaired and/or
proteins may become more readily accessible to the
systemic immune system in the absence of SAbs.
The detection of serum albumin in the saliva and
faeces suggest protein leakage across the epithelial
barrier (Johansen et al. 1999), a sign of increased
permeability at such sites. Increased trafficking from
the gut also extends to microbes in pIgR−/− mice.
We observed that uptake of dominant commensal
bacterial species into the mesenteric lymph nodes
(mLNs) is increased in pIgR-deficient mice (Sait et
al. 2007), highlighting an important role for SAbs in
maintaining the integrity of the gut barrier. The
capacity for controlling microbial influx has signifi-
cant implications for mucosal immunity against
pathogens in the GIT. We have shown that SAbs in
naïve mice provided substantial protection against
Salmonella invasion of the gut (Wijburg et al. 2006).
Orally administered Salmonella disseminated to the
Peyer’s Patches and mLNs earlier and in greater
numbers in pIgR−/− mice, which also showed in-
creased shedding of the bacteria in the faeces.
Therefore, SAbs are functionally important for con-
ferring resistance to gut infection as well as for re-
ducing the transmission of pathologic gut bacteria.
To date, much of the attention has focussed on the
role of the pIgR in infectious disease immunity and
transmission (Uren et al. 2005), and there is considerably
less research on the role of Sab in mucosal homeostasis.
It is suggested that disruptions to mucosal homeostasis
in mice lacking SAb could arise when environmental an-
tigens that would normally be neutralised and removed
from the lumen, lamina propria (LP) and epithelium by
SIgA and pIgR, are retained or accumulated (Strugnell
and Wijburg 2010). The downstream effects of the fail-
ure to neutralise and remove antigen could potentially
include heightened activation of immune cells in the
GIT following increased ‘pathogen’ sensing through
PAMPs; this leads to immune activation, structural dam-
age to the epithelial barrier due to inflammation, and
subsequent loss of integrity of the epithelial barrier. Ac-
cordingly, several groups have shown pIgR−/− mice are
more likely to develop systemic Ab responses against
normal flora and have increased numbers of
antibody-secreting cells (ASCs) in gastric-associated tis-
sues (Sait et al. 2007; Johansen et al. 1999; Uren et al.
2003), a phenomenon that may have broader implica-
tions on the health and development of the host.
This study aimed to further explore the role of the
secretory immune system in limiting the inflammation
and permeability of the GIT under homeostatic con-
ditions. Our data show a relative delay in growth in
pIgR−/− mice compared with their wild-type counter-
parts, a phenomenon associated with increasing infil-
tration of intraepithelial lymphocytes (IELs) that were
high in surface expression of CD103 and CD69 char-
acteristic of tissue resident memory T cells (reviewed
in (Carbone 2015)). Using advanced
gas-chromatography mass spectrometry (GC-MS) ana-
lysis, we found that pIgR−/− mice displayed signifi-
cantly altered metabolite markers in the urine,
suggesting increased translocation of gut luminal con-
tents into the murine host. Further investigations
through direct measure of gut permeability in mice
lacking SAbs indicate that the urinary metabolome
profile can be used as a non-invasive method for
measuring gut permeability.
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Methods
Mice
The colony of B6.pIgR−/− mice used in this study were
generated by targeted mutagenesis of C57BL/6 (B6) mice
as described (Uren et al. 2003) and maintained in the
animal facility of the Department of Microbiology and
Immunology, The University of Melbourne. Control B6
mice were maintained in the same breeding facility. All
mice were bred and housed under SPF conditions and
received food and water ad libitum. All mice were age
and sex-matched for each experiment. Mice were
weighed at regular intervals from weaning. All animal
experiments were approved by The University of Mel-
bourne Animal Ethics Committee, and were compliant
with the Prevention of Cruelty to Animals Act (1986)
and the National Health and Medical Research Council
(NHMRC) Australian Code of Practice for the Care and
Use of Animals for Scientific Purposes (1997).
Cell preparation and flow cytometry
The small intestine was excised, washed in PBS, cut
open longitudinally and then into 2 cm pieces. Intestinal
pieces were incubated at 37 °C for 1 h with gentle shak-
ing in dissociation buffer (3% foetal calf serum and 5
mM EDTA in HBSS) to release IELs. The mixture was
filtered through a 70 μm cell strainer and washed twice
in FACS/EDTA buffer (0.1% bovine serum albumin and
5mM EDTA in PBS). Cells were centrifuged in 37% iso-
tonic Percoll (GE Healthcare) for 20 min at 900×g. Lym-
phocytes were harvested from the pellet at the end of
the centrifugation, washed twice and resuspended in
FACS/EDTA buffer. For flow cytometry, 100 μl of cell
suspension was incubated with fluorochrome-conjugated
antibodies for 30 min on ice. The following antibodies
(clone) were purchased from BD Bioscience or
eBioscience: CD45 (30-F11), CD4 (GK1.5), CD8α (53–
6.7), TCRβ (H57–597), TCRγδ (GL3), CD103 (2E7),
CD69 (H1.2F3). MAIT cell-specific MR1 tetramer was
obtained from James McCluskey (Reantragoon et al.
2013; Corbett et al. 2014), The University of Melbourne.
NKT cell-specific CD1d tetramer was obtained from
Dale Godfrey (Hammond et al. 2001), the University of
Melbourne. After staining, cells were washed twice in
FACS/EDTA buffer and propidium iodide (Sigma) was
added for exclusion of dead cells immediately before
analysis using the LSRII flow cytometer (BD Bioscience).
Calibration beads (BD Bioscience) were used for cell
counting on the flow cytometer. FACS data was analysed
using FlowJo software (TreeStar).
Cytokine analysis
For collection of serum, peripheral blood was drawn by
cardiac bleeding immediately after euthanasia. Blood
samples were allowed to clot for at least 3 h at room
temperature, and serum was separated following two
rounds of centrifugation. Whole section of small intes-
tine was homogenised in 2 ml RPMI (Life Technologies)
and complete EDTA-free protease inhibitor (Roche) was
added to inhibit protein degradation. Gut content and
debris was removed by three rounds of centrifugation
for collection of cytokine-containing supernatant. The
concentration of IL-2, IL-4, IL-6, IL-10, IL-17A, IFN-γ
and TNF was determined using the Mouse Th1/Th2/
Th17 cytometric bead array (BD Bioscience) according
to manufacturer’s instructions. Data was analysed using
the FCAP Array software (BD Bioscience).
GC-MS for metabolite analysis of urine
Urine (20 μL) was incubated with an equal volume of
urease (20 μL, 0.5 units/μL in water, Sigma) at room
temperature for 15 min to remove excess urea. Samples
were then mixed with chilled ethanol (160 μL, contain-
ing 62.5 μM scyllo-inositol internal standard) to precipi-
tate the urease and urinary proteins, for the extraction
of urine metabolites. Samples were centrifuged (0 °C, 5
min. 14,000 rpm) and an aliquot of the resultant super-
natant (20 μL) dried in vacuo prior to chemical derivati-
sation for GC-MS analysis. Chemical derivatisation and
instrument conditions were as described in Long et al.
(Long et al. 2015). Standard curves were produced for
each sugar and quantification in mouse urine was
achieved with the use of scyllo-inositol as an internal
standard. The detection limit for the four sugars was cal-
culated to be within the range of 100–300 pM/L. Inter-
and intra-assay coefficients of variation were less than
4.5 and 10.2%, respectively. AnalyzerPro software (Spec-
tralworks, Runcorn, UK) was used to process the raw
data.
For discovery of biomarkers, 272 urine metabolites
were aligned and normalised for multivariate statistical
analysis. The spectra of all resolved peaks were
annotated by comparison to commercially available
electron impact mass spectral libraries such as the NIST
(Http://www.nist.gov) or AMDIS (Http://chemdata.nist.
gov/mass-spc/amdis). The standard compounds that are
assumed present at detectable levels within urine, were
measured.
Measurement of gastrointestinal permeability using sugar
probes
GI permeability was assessed using a method adapted
from Meddings and Gibbons (Meddings and Gibbons
1998). To validate the system, gastric damage was in-
duced by a single oral gavage of aspirin (250 mg/kg in
75% ethanol) via a 4 cm gastric needle under light an-
aesthesia using Penthrane (Abbot Laboratories). Two
hours later, mice received a single oral 200 μL inocu-
lation containing sucrose 120 mg/mL, mannitol 30
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mg/mL, lactulose 60 mg/mL and sucralose 30 mg/mL
(Sigma). Urine was collected at 1 to 4-h intervals for
24 h after inoculation of the sugars in 10% thymol in
isopropanol. Samples, including scyllo-inositol which
was used as an internal standard, were weighed,
urease-treated and ethanol extracted before GC-MS
analysis. All samples were analysed in duplicate using
an Agilent 7890 gas chromatograph, coupled to a
5975C mass selective detector. GC separations were
performed using a Varian VF-5 ms capillary column.
Standard curves were produced for each sugar and
quantification in mouse urine was achieved with the
use of scyllo-inositol as an internal standard. The in-
ternal standard and sugar probes eluted as follows:
scyllo-inositol 20.8 min, mannitol 19.9 min, sucrose
26.0 min, sucralose 26.6 min and lactulose 26.4 min.
The detection limit for the four sugars was calculated
to be within the range of 100–300 pM/L. Inter- and
intra-assay coefficients of variation were less than 4.5
and 10.2%, respectively. AnalyzerPro software was
used to process the raw data.
Statistical analysis
Annotated urine metabolites were normalised by mean
absolute deviation (MAD). To determine the relation-
ship between samples, sparse partial least square dis-
criminant analysis (sPLS-DA) was computed using the
mixOmics R package (available through: mixomics.org/
access/download). GraphPad Prism (v7) was used for
statistical analyses; unpaired t test was used for compari-
son between two groups, or one-way ANOVA was used
between three groups. The non-parametric Mann Whit-
ney U-test was used for statistical analysis of ratios.
Results
The loss of SIgA is associated with pathology in the gut
The pIgR is responsible for secreting SAbs into the
gut lumen. Comparable to earlier reports from our
lab as well as others (Johansen et al. 1999; Uren et
al. 2003; Shimada et al. 1999), our colony of pIgR−/−
mice exhibited a severe deficiency of SIgA in the fae-
cal extract (Additional file 1: Figure S1A) and subse-
quently a significant accumulation of IgA in the
serum (Additional file 1: Figure S1B), while no ap-
parent deficiency was observed with IgG in either
the faeces (Additional file 1: Figure S1C) or the
serum (Additional file 1: Figure S1D). These data
confirm that pIgR−/− mice carry a deficiency of SIgA
in the gut.
It has been suggested that the deficiency of SAbs could
affect the local intestinal environment through its role in
regulating the microbiome (Reikvam et al. 2012; Rogier
et al. 2014). However, we were unable to detect varia-
tions in the microbial community composition that
could be attributed to the pIgR genotype using
culture-independent techniques to profile the biodiver-
sity of the terminal ileum (Sait et al. 2003). Alternatively,
it is possible that SAbs maintain intestinal homeostasis
by exerting a suppressive effect on inflammatory re-
sponses to commensal bacteria and common metabolites
in the gut lumen. We found that while the GIT appeared
healthy in young adult pIgR−/− mice (2 months of age,
Fig. 1a left panels), a range of abnormalities was ob-
served in the duodenum and colon of 18-month-old
pIgR−/− mice (Fig. 1a right panels), with key pathological
indicators including reduced mucin, larger nuclei in
crypt epithelium and substantial lymphocytic infiltration
in older animals. Such immunopathology was seen in a
statistically significant proportion of pIgR−/− mice at 18–
24months of age but was absent from age-matched B6
mice (Fig. 1b). These observations suggest that cumula-
tive GIT damage takes place in the absence of SAbs and
the pathology intensifies as mice age.
Aged pIgR−/− mice display an increase in T cell-mediated
inflammation in the GIT
The ‘excretory immune system’ hypothesis posits that
the loss of SAbs results in an accumulation of antigens
on the basolateral surface of the mucosal epithelia
(Strugnell and Wijburg 2010; Robinson et al. 2001), lead-
ing to lymphoproliferation in the epithelium and lamina
propria. Recently, several subsets of innate-like, invariant
T cells, including natural killer T (NKT) cells (Midden-
dorp and Nieuwenhuis 2009) and mucosal-associated in-
variant T (MAIT) cells, have been speculated to play a
physiological role in the GIT. Whether a compensatory
relationship exists between these T cells and SAbs re-
main to be determined. To characterise the phenotype
of infiltrating lymphocytes, we isolated IELs from the
small intestine (SI) of pIgR−/− and age-matched B6 mice.
Similar to a previous report (Yamazaki et al. 2005), we
found a significantly increased accumulation of SI-IELs
in pIgR−/− compared to B6 mice at 12 weeks of age, and
the difference became especially prominent as mice aged
to 34 weeks (Fig. 2a). Compared with B6 mice, SI-IELs
in pIgR−/− mice were enriched for αβ+ T cells (Fig. 2a).
Notably, we observed that invariant αβ+ T cells, includ-
ing MAIT cells (Fig. 2b) and NKT cells (Fig. 2c), were
not enriched within the SI-IELs of pIgR−/− mice, whereas
conventional CD8α+αβ+ T cells (Fig. 2d) were the most
abundant cell type infiltrating the small intestine.
Similar to their wild-type counterpart, CD8α+αβ+ T
cells within the SI-IEL of pIgR−/− mice co-expressed
high levels of E-cadherin receptor CD103 and TCR
engagement marker CD69 (Fig. 2e, top row), which
are characteristic of tissue resident memory T cells
(TRM). Enhanced accumulation of these cells likely re-
sulted from ongoing stimulation from gut microbiota
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or metabolite in pIgR−/− mice. Furthermore, we ob-
served that pIgR−/− mice carried an increased number
of CD4+αβ+ T cells within SI-IELs (Fig. 2d). As mice
became older, a sub-population of CD4+αβ+ T cells
that expressed CD103 also upregulated CD8α expres-
sion (Fig. 2e, bottom row). We also tested for the
presence of cytokines linked with inflammation in
the supernatant from SI homogenate of 45-week old
mice, as well as serum from 12-, 34- and 45-week
old mice using cytometric bead array (CBA). IL-2,
IL-4, IL-6, IL-10, IL-17A, IFN-γ and TNF were
tested; only IFN-γ was detected in the SI of all
pIgR−/− mice (Fig. 2f ). Flow cytometric analysis
showed that an increased number of SI CD4+ αβ+ T
cells produced IFN-γ after ex vivo re-stimulation
with anti-CD3 antibody (data not shown), indicating
that infiltrating αβ+ T cells most likely have a patho-
logical effect in the gut of pIgR−/− mice.
Collectively our results show a strong correlation be-
tween CD8α+αβ+ T cell infiltration and GIT pathology
in pIgR−/− mice, while a unique sub-population of
CD4+CD8α+ double-positive (DP) αβ+ T cells may de-
velop over time to neutralise the Th1-biased local envir-
onment in GIT.
A
B
Fig. 1 Age-dependent immunopathology in the GIT of pIgR−/− mice. a Intestine sections of 2-month and 18-month old male B6 and pIgR−/−
mice were stained with H&E. Representative sections of duodenum, ileum and colon were imaged at 20× magnification. Arrows indicate
pathology in duodenum of 18-month old pIgR−/− mice. b Intestine sections were graded blindly by a pathologist. Intestines were described as
normal or affected. Affected tissue exhibited a reduction in mucin, larger nuclei in crypt epithelium and seemingly increased number of
lymphocytes. Affected samples are noted in the table. Statistical analysis was performed using a two-tailed Fisher’s exact test, ns indicates
p-values > 0.05
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Fig. 2 (See legend on next page.)
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Delayed growth is associated with metabolic
abnormalities in pIgR−/− mice
We hypothesised that prolonged and escalating inflam-
mation in the gut could impact on the integrity of the
GI tract, which may in turn affect nutritional uptake and
growth in pIgR−/− mice. Intriguingly, we noticed that
male pIgR−/− mice appeared smaller and showed reduced
body weight at the time of weaning (3–4 weeks of age)
compared to their wild-type counterpart (Fig. 3a), an ap-
parent delay in growth that may at least in part be attrib-
utable to reduced IgA level in the maternal breast milk
(Rogier et al. 2014). To determine whether the lack of
SAbs has lasting effect on growth into the adult-
hood, we established a large cohort of male and
female B6 and pIgR−/− mice and monitored their
body weight from 4 weeks of age. We observed that
the pIgR−/− mice maintained a smaller body weight
compared to age- and sex-matched wild-type con-
trols at each time point taken, a trend that was most
pronounced in the male animals (Fig. 3b), although
the percentage weight gain since weaning at 4 weeks
of age remained comparable between the genotypes
for both sexes (Fig. 3c). This indicates that the defi-
ciency of SAbs leads to a sustained but not
(See figure on previous page.)
Fig. 2 Flow cytometric analysis of small intestine intra-epithelial lymphocytes (IELs) reveals enrichment of αβ+ T cell subsets in older pIgR−/− mice.
IELs were collected from age- and sex-matched B6 (closed circle, 12-week n = 7, 34-week n = 14) and B6.pIgR−/− (open circle, 12-week n = 8, 34-
week n = 11) mice. a The total number of small intestine IELs (SI-IELs, CD45+), αβ+ T cells (TCRβ+) and γδ+ T cells (TCRγδ+) was increased in pIgR−/
− mice compared to B6 mice. Representative FACS profiles of SI-IEL αβ+ T cell are shown for b MAIT cells by MR1 tetramer staining with SI-IELs
from Vα19i MAIT cell transgenic mice as positive control for gating (Kawachi et al. 2006), and c NKT cells by CD1d tetramer staining with
splenocytes as positive control for gating. The number of d SI-IEL CD8α+αβ+ T cells (TCRβ+CD8α+CD4−) and SI-IEL CD4+αβ+ T cells (TCRβ+CD4+)
was significantly increased in pIgR−/− mice especially with age, and e representative FACS profiles for these subsets are shown. f Serum was
collected from B6 and pIgR−/− mice at indicated age and small intestine was homogenised in 2 ml RPMI. The concentration of IFN-γ was
determined using mouse Th1/Th2/Th17 cytometric bead array (CBA). Dotted line indicates detection limit (DL). Data points indicate individual
mice that were pooled from 3 to 4 independent experiments, mean ± SEM is shown. Unpaired t-test was used for statistical analyses and p-values
are shown where < 0.05 is considered significant
A
C
B
Fig. 3 Effect of pIgR deletion on mouse body weight in B6 mice. Cohorts of age- and sex-matched male (closed circle, B6 n = 15; open circle,
pIgR−/− n = 10) and female (closed diamond, B6 n = 10; open diamond, pIgR−/− n = 10) mice were weighed at indicated age. Shown are a body
weight of individual mice at 4 weeks of age; and b mean ± SEM body weight over a 65-week time course. c Proportional weight gain is
calculated as weight gained since 4 weeks of age as a percentage of 4-week body weight of the same mouse
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exacerbated delay in weight building over an ex-
tended period of time.
We next examined whether nutritional intake was
altered in pIgR−/− mice that showed reduced growth.
GC-MS was used to determine the urinary concentra-
tions of 42 specific metabolites, and sparse partial least
square discriminant analysis (sPLS-DA) was performed
to demonstrate whether urine samples, based on the
profile of these 42 metabolites, segregated according to
the pIgR genotype. As shown in the scores plots, which
represent the distribution of samples in multivariate
space, a clear separation between groups of male pIgR−/−
and B6 mice was observed (Fig. 4a), and a similar
trend was also seen with urine samples from female
mice (Fig. 4b). These results indicate that deficiencies
in SAbs is correlated with metabolic abnormalities in
pIgR−/− mice.
To identify metabolites responsible for the group sep-
aration between B6 and pIgR−/− mice, we used Student’s
t-test to compare the abundance of individual urinary
metabolites between B6 and pIgR−/− mice. Using this ap-
proach, we identified 20 urinary metabolites that were
differentially presented between pIgR−/− mice and their
wild-type counterparts in at least one sex, as highlighted
in Table 1. This includes several compounds that are dir-
ectly or indirectly involved in the tricarboxylic acid
(TCA) cycle, such as citric acid, cis-aconitate, succinic
acid and Vitamin B5 (pantothenic acid). In particular,
pantothenic acid is required for the synthesis of coen-
zyme A and hence acetyl CoA; consistent with a reduc-
tion in pantothenic acid, both acetyl CoA and
propanoate were decreased in the urine of pIgR−/− mice.
Three urinary metabolites, fucose, glycine and pantothe-
nic acid, showed the strongest discrepancy between
pIgR−/− and B6 mice (Fig. 5). The level of fucose and gly-
cine was elevated, whereas pantothenic acid was reduced
in the mice lacking secretory antibodies and, consistent
with other indicators of pathology, the difference was
most significant in male mice.
Increased epithelial permeability in pIgR−/− mice as shown
by altered ratios of sugar probes excreted in the urine
The detection of potential microbiota-derived metabo-
lites in the urine of pIgR−/− mice suggested increased
epithelia permeability through the loss of SAbs in pIgR−/
− mice. To measure GIT permeability, we adapted the
method described by Meddings & Gibbons (Meddings
and Gibbons 1998) that utilised four sugar probes:
sucrose, lactulose, mannitol and sucralose, which are
absorbed in different regions of the GIT. The sugars
were fed to mice and permeability was assessed by
measuring excretion ratios (i.e. ingested versus excreted)
in the urine. The presence of urinary sucrose is used as
an indicator of increased stomach and duodenal
permeability, lactulose and mannitol can indicate in-
creased permeability of the small intestine, and sucralose
can be used to assess all regions of the gut, including the
large bowel.
To confirm that this approach can detect GI damage,
we first fed wild-type B6 mice with a dose of 5 mg
aspirin to induce GIT permeability, two hours prior to
oral gavage with the four sugars. Twenty-four hours fol-
lowing treatment, mice that received aspirin showed
pathology in the GIT (data not shown). GC-MS analysis
of urine samples revealed a distinct change in the ratio
of sugar probes after aspirin treatment (Fig. 6a), such
that increased permeability in the small intestine was as-
sociated with increased ratios of lactulose to mannitol
and lactulose to sucralose, whereas increased permeabil-
ity in the large intestine led to decreased ratio of sucrose
to lactulose similar to described before (Meddings and
Gibbons 1998).
To determine the effect of SAbs on GIT permeability,
age-matched pIgR−/− and B6 wild-type mice were fed a
bolus dose of sugar probes by oral gavage and urine
samples were collected 24 h post-feeding. At 10-weeks
of age, there was no difference in the sugar ratios be-
tween age-matched B6 and pIgR−/− mice (Fig. 6b), sug-
gesting that the GIT barrier is not compromised in
young pIgR−/− mice. In older pIgR−/− mice (22 weeks of
age), there was a significant increase in the ratio of lac-
tulose to mannitol and lactulose to sucralose compared
to B6 mice (Fig. 6c), indicating that pIgR−/− mice show
increased epithelial permeability in the small intestine.
Similarly, we observed a decrease in the ratio of sucrose
to lactulose and sucralose to mannitol in pIgR−/− mice
compared with B6 mice (Fig. 6c), indicating increased
epithelial permeability in the large intestine of pIgR−/−
mice. There was no change in the ratio of sucrose to
mannitol between B6 and pIgR−/− mice that indicate
stomach permeability (data not shown). Collectively,
these results suggest that ageing pIgR−/− mice have dem-
onstrably greater permeability in the small and large in-
testines where cumulative pathology (Figs. 1 and 2) has
been observed.
Discussion
The mucosal immune system of the GIT plays a key role
in preventing infection and damage by pathogenic
organisms and their toxins. In this environment, the
damage caused by immune responses to colonising
microbiota and environmental molecules must be mini-
mised, whilst also allowing the primary function of nu-
trient absorption to occur. The pIgR is expressed on the
basolateral surface of columnar epithelial cells and is an
essential component of the antibody secretion pathway.
Studies utilising pIgR−/− mice have been used to support
the hypothesis that pIgR and SAbs are important for
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maintaining immune homeostasis of the mucosal
lumen, and limiting mucosal and systemic immune re-
sponses to non-pathogenic environmental antigens (such
as normal flora and food), through antigen ‘excretion’, a
hypothesis first developed by Michael Lamm et al. in 1991
(Kaetzel et al. 1991). Under the excretion hypothesis, fail-
ure to excrete antigen can result in enhanced immune ac-
tivation. We have shown that transgenic CD4+ T cells
specific for ovalbumin proliferated to a higher extent in
pIgR−/− mice compared with B6 mice after oral feeding of
A
B
Fig. 4 Scores plot analysis of metabolite profiles in urine of B6 and pIgR−/− mice. GC-MS was performed on urine samples to determine the
profile of metabolites excreted in the urine of a male and b female B6 and pIgR−/− mice. To control for sample variation due to urine volume and
concentration, the annotated urine metabolites were normalized by Mean Absolute Deviation (MAD). Data was analyzed by sPLS-DA and scores
plot, with 95% confidence intervals of the sample space highlighted by elliptical boundaries
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Table 1 Compounds identified in urine metabolic profiles of B6 and pIgR−/− male & female mice.
Statistical analysis of data normalised by MAD was performed using Student’s t-test, and p-values are given. Statistically significant differences where pIgR−/−
metabolite values were greater than B6 are highlighted in green, and decreases are highlighted in red. Statistically significant p-values are highlighted by
*p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001
Simpfendorfer et al. Molecular Medicine           (2019) 25:12 Page 10 of 14
ovalbumin (Sait et al. 2007), suggesting there may be im-
paired tolerogenic mechanisms in the absence of SAbs. It
has also been reported that, in the absence of pIgR and
SAbs, B6 mice have increased uptake of gut commensal
bacteria into the mLNs, and this is associated with higher
levels of antibodies specific to commensal bacteria (Sait et
al. 2007; Johansen et al. 1999).
Previous studies have highlighted the role of SAbs in
maintaining the integrity of the GIT, typically analysed
using young mice, little was known about the long-term
effect that low-grade but persistently increased gut per-
meability may have on the general health of the individ-
ual. In this study, we followed the development of B6
and isogenic mice deficient for SAbs (pIgR−/−) for more
than 12months. The delayed gain in body weight seen
in pIgR−/− mice was most obvious in males and was ob-
served from 4 weeks of age, although signs of gross path-
ology, such as increased lymphocytic infiltration, damage
to the epithelial layer of the GIT and increased perme-
abilities to sugar probes, became increasingly more ap-
parently with age. This indicates a slow but cumulative
effect that the absence of SAbs has on the health of GIT
under homeostasis. Reduced weight gain can be due to
reduced nutrient intake or increased metabolism, or
both, and is often associated with an increase in GI per-
meability and/or inflammation of the gut, such as occurs
in HIV enteropathy during AIDS (Bjarnason et al. 1996;
Murphy et al. 1999). We show that this delay in growth
was associated with an altered urine metabolome; in par-
ticular, a group of 20 metabolites differentiated the two
genotypes of animals in a multivariate analysis. This ef-
fect was again the strongest in male mice, which also
had a stronger phenotype for delayed growth. A number
of the metabolites with altered concentrations in pIgR−/−
mice were components of the TCA cycle, e.g. a defi-
ciency in pantothenic acid (Vitamin B5), required for the
synthesis of coenzyme A. Since many of these metabolites
can be derived from both eukaryotic and prokaryotic me-
tabolism, it is not possible to identify their source.
To investigate whether these changes in the urine me-
tabolome were associated with functional changes in
GIT function, we measured GIT permeability using a
modified sugar feeding assay. This assay was validated
A
B
C
Fig. 5 Specific metabolites in the urine of B6 and pIgR−/− mice. GC-
MS was performed on samples to determine the profile of
metabolites excreted in urine of male (closed circle, B6 n = 17; open
circle, pIgR−/− n = 19) and female (closed diamond, B6 n = 9; open
diamond, pIgR−/− n = 10) mice. Samples were urease treated, ethanol
extracted and analysed by GC-MS with myo-inositol as internal
control and individual sugars quantitated using a standard sugar mix
to determine response factors. Normalized peak area values are
shown for a fucose, b glycine and c pantothenic acid. Unpaired t-test
was used for statistical analyses and p-values are shown, ns indicates
p-value > 0.05
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following aspirin-induced GIT damage, which has previ-
ously been shown to alter GI permeability to sugar
probes in rodents (Meddings and Gibbons 1998;
Worthington et al. 1978; Alnadjim et al. 2002). Using
this assay, we demonstrated that aged mice lacking
SAbs, but not younger mice, had demonstrably increased
permeability, a phenomenon that was not observed in
wild-type animals. The increased permeability was asso-
ciated with an increase in immunopathology. The effect
was most marked in the duodenum and colon and char-
acterized by a reduction in mucin, larger nuclei in crypt
epithelium and increased lymphocyte numbers.
The increased gut permeability seen in pIgR−/− animals
is also observed in other diseases and conditions affect-
ing the GIT, which present as significantly delayed
growth or a failure to thrive (Arrieta et al. 2006). These
include gastrointestinal ‘allergy’ (Zanjanian 1976), Celiac
disease (Vogelsang et al. 1998), Crohn’s disease and
ulcerative colitis (Munkholm et al. 1994; Söderholm et
al. 1999a; Söderholm et al. 1999b; Hollander 2002), irrit-
able bowel syndrome (Barau and Dupont 1990), type 1
diabetes (Secondulfo et al. 2004) and infection (Ding et
al. 2004). These studies suggest that immunodeficiencies
that are characterized by impaired B cell function and
reduced levels of IgA and IgM (e.g. common variable
immune deficiency, CVID), and which are associated
with mucosal inflammatory and autoimmune diseases
(Cunningham-Rundles 2010) that might result from the
loss of the antigen ‘excretion’ pathway (Strugnell and
Wijburg 2010), a pathway facilitated by SAbs.
We noted that lymphocytic infiltration in pIgR−/− mice
was enriched for CD8α+αβ+ T cells of an apparent resi-
dent memory phenotype (CD103+CD69+), and the en-
richment was enhanced with age. We speculate that
excess accumulation of these cells in the GIT of pIgR−/−
mice most likely occurred in response to ongoing
A
B
C
Fig. 6 Gastrointestinal permeability of older adult mice to sugar probes. Gastrointestinal permeability was measured as altered ratios of sugar
probes excreted in the urine. a B6 mice were treated with 5 mg aspirin two hours prior to feeding with sugar probes (open star sign, untreated
n = 14; closed star sign, treated n = 6). b 10-week old or c 22-week old female B6 (closed diamond) or pIgR−/− (open diamond) mice were given
an oral dose of sugar probes containing sucrose, lactulose, sucralose and mannitol. The concentration of sugar probes in urine was collected 24-h
post feeding and analysed by GC-MS. Data are represented as the ratio of sugar probe concentrations within samples and the horizontal bar
represents the mean of each group. Statistical analysis was performed using the Mann Whitney U-test, ns indicates p > 0.05. Data are pooled from
two independently performed experiments
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stimulation from gut microbiota and metabolites. In
addition, these CD8α+αβ+ TRM may be the primary me-
diator of GIT pathology due to their capacity of produ-
cing cytotoxic granzyme B (Casey et al. 2012). We also
observed the infiltration of CD4/CD8 double positive
(DP) αβ+ T cells. Peripheral CD4/CD8 DP T cells have
been detected in a number of disease models and across
several species (reviewed in (Overgaard et al. 2015)).
The role of these cells appears to be disease-specific,
ranging from pro-inflammatory in cancer models, to
suppressive Treg functions in the gut (Das et al. 2003).
Although the majority of 34-week old pIgR−/− mice har-
boured an increased number of CD4/CD8 DP T cells,
the absolute number of these cells varies widely between
individual animals. Whether the expansion of these cells
dampens, or further contributes to immune pathology, re-
mains unclear.
Conclusions
Our observations suggest that the absence of SAbs in
otherwise healthy animals is associated with increased
inflammation of the epithelium, increased GIT perme-
ability and altered metabolism as the consequence, lead-
ing to delayed growth. The lymphocytes that accumulate
in the epithelia appear phenotypically to be conventional
CD8+ T cells, not NKT cells or MAIT cells. MAIT cells
are activated by riboflavin metabolites produced by the
microbiota (Corbett et al. 2014). These studies, con-
ducted under SPF environment, suggest that the pIgR
and SAbs play an important role in maintaining homeo-
stasis of the uninfected GIT and limit mucosal and sys-
temic immune responses to notionally non-pathogenic
environmental antigens, perhaps in concert with PAMPs,
such as LPS, CpG DNA, peptidoglycan (Mills 2011) re-
leased from the microbiota (Wang et al. 2015). Urine
metabolite analysis revealed several potential biomarkers
for failure to thrive, including increased succinate levels.
Notably, severely malnourished children also demon-
strate elevated succinate levels in their urine (Capo-Chi-
chi et al. 2000). These observations suggest that cases of
human ‘failure to thrive’ might result from micro-inflam-
mation of the epithelia resulting from loss of antibody
secretion, warranting further investigation.
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